Background illustration for clinical trials search

Paid Clinical Trials Springfield

Discover 203 paid clinical trials in Springfield, Illinois. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression

for
Acute Lymphoblastic Leukaemia, Acute Myeloid Leukaemia,
Location: Decatur IL, Durham NC, Houston TX
Sponsor: AstraZeneca

Sex: All

Age: 16+

Code: NCT07155226

Phase 1, Phase 2, Recruiting

DESTINY-PANTUMOUR04

for
Adenocarcinoma (NOS), Anal Cancer, Bladder Cancer,
Location: Decatur IL, Nashville TN, Topeka KS, Maumee OH,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT07124000

Recruiting

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Non-Squamous NSCLC

for
Non-squamous Non-small Cell Lung Cancer
Location: Decatur IL, Bridgeton MO, Quincy IL, Hinsdale IL,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06627647

Phase 3, Recruiting

A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer

for
Carcinoma, Non-Small Cell Lung
Location: Decatur IL, Bridgeton MO, Chicago IL, Owensboro KY,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06868277

Phase 3, Recruiting

Education & Mentorship of Advanced Practice Providers to Increase Community-based Research Within the NCORP Network, COACH-APP Trial

for
Other
Location: Pekin IL, Bloomington IL, Washington IL, Eureka IL,
Sponsor: Wake Forest University Health Sciences

Sex: All

Age: 18+

Code: NCT06904391

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

for
Advanced Non-Small Cell Lung Cancer, Non-Small Cell Lung Cancer,
Location: Pekin IL, Bloomington IL, Washington IL, Peoria IL,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07222566

Phase 3, Recruiting

Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer

for
Astrocytoma, IDH-Mutant, Grade 3
Location: Pekin IL, Canton IL, Bloomington IL, Peoria IL,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 12+

Code: NCT07215910

Phase 3, Recruiting

Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer

for
Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction , or Esophageal Adenocarcinoma,
Location: Pekin IL, Bloomington IL, Washington IL, Peoria IL,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07392892

Phase 2, Phase 3, Recruiting

Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer

for
Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,
Location: Pekin IL, Canton IL, Bloomington IL, Peoria IL,
Sponsor: NRG Oncology

Sex: All

Age: 18+

Code: NCT06532279

Phase 2, Recruiting

A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

for
Non-small Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic,
Location: Pekin IL, Bloomington IL, Washington IL, Peoria IL,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07144280

Phase 3, Recruiting

Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial

for
Castration-Resistant Prostate Carcinoma,
Location: Pekin IL, Canton IL, Bloomington IL, Washington IL,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18+

Code: NCT06632977

Phase 2, Recruiting

A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease

for
COVID-19 SARS-CoV-2 Infection
Location: Morton IL, Louisville KY, Columbus OH, Papillion NE,
Sponsor: Pfizer

Sex: All

Age: 12+

Code: NCT06679140

Phase 3, Recruiting

A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M)

for
Irritable Bowel Syndrome
Location: Morton IL, Hazelwood MO, Oak Lawn IL, Ames IA,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18 - 70+

Code: NCT07519395

Phase 2, Recruiting

INTEGRATED CHILDHOOD ACTIVITY AND NUTRITION (ICAN) STUDY

for
Achievement, Weight Change, Cognition, Fitness,
Location: Bloomington IL
Sponsor: University of Illinois at Urbana-Champaign

Sex: All

Age: 6 - 11

Code: NCT07011602

Recruiting

Consistently Assess Signs and Symptom of Heart Failure

for
Heart Failure, Heart Failure With Reduced Ejection Fraction,
Location: Normal IL
Sponsor: Board of Trustees of Illinois State University

Sex: All

Age: 18 - 70+

Code: NCT05833581

Recruiting

Treatment With Amivantamab and Hyaluronidase or Cetuximab for Advanced Skin Cancer in People With a Weakened Immune System

for
Locally Recurrent Skin Squamous Cell Carcinoma,
Location: Normal IL, Effingham IL, Mattoon IL, Urbana IL,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT07042295

Phase 2, Recruiting

Sacituzumab Govitecan With Bevacizumab Compared to Usual Chemotherapy (Carboplatin, Pegylated Liposomal Doxorubicin and Bevacizumab) for Treating Recurrent Platinum-Sensitive Ovarian Cancer After PARP Inhibitor Maintenance Therapy

for
Recurrent Platinum-Sensitive Fallopian Tube Endometrioid Adenocarcinoma,
Location: Normal IL, Effingham IL, Mattoon IL, Urbana IL,
Sponsor: National Cancer Institute (NCI)

Sex: Female

Age: 18+

Code: NCT07504588

Phase 2, Recruiting

Testing the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescents and Adults With Advanced Adrenocortical Cancer

for
Locally Advanced Adrenal Cortical Carcinoma,
Location: Normal IL, Effingham IL, Mattoon IL, Urbana IL,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 12+

Code: NCT06900595

Phase 2, Recruiting

Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma

for
Endometrial Adenocarcinoma,
Location: Normal IL, Effingham IL, Mattoon IL, Urbana IL,
Sponsor: National Cancer Institute (NCI)

Sex: Female

Age: 18+

Code: NCT05112601

Phase 2, Recruiting

The ECOG-ACRIN SUPPORT Trial: Multilevel Intervention to Improve Diverse Enrollment in Cancer Clinical Trials

for
Cancer
Location: Normal IL, Bloomington IL, Effingham IL, Mattoon IL,
Sponsor: Eastern Cooperative Oncology Group

Sex: All

Age: 18+

Code: NCT06756607

Recruiting